Kara Hanson

Author PubWeight™ 129.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet 2012 6.40
2 What can be done about the private health sector in low-income countries? Bull World Health Organ 2002 4.87
3 Achieving universal coverage with health interventions. Lancet 2004 4.29
4 Improving the health of the global poor. Science 2002 3.69
5 Building the field of health policy and systems research: an agenda for action. PLoS Med 2011 3.54
6 Building the field of health policy and systems research: social science matters. PLoS Med 2011 3.46
7 Building the field of health policy and systems research: framing the questions. PLoS Med 2011 3.21
8 To retain or remove user fees?: reflections on the current debate in low- and middle-income countries. Appl Health Econ Health Policy 2006 3.06
9 Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J 2011 2.99
10 Scaling up in international health: what are the key issues? Health Policy Plan 2010 2.96
11 Costs and consequences of large-scale vector control for malaria. Malar J 2008 2.93
12 Is malaria a disease of poverty? A review of the literature. Trop Med Int Health 2005 2.88
13 Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J 2011 2.75
14 Which delivery systems reach the poor? A review of equity of coverage of ever-treated nets, never-treated nets, and immunisation to reduce child mortality in Africa. Lancet Infect Dis 2005 2.39
15 Scaling-up and sustaining insecticide-treated net coverage. Lancet Infect Dis 2003 2.27
16 Do malaria control interventions reach the poor? A view through the equity lens. Am J Trop Med Hyg 2004 2.23
17 Inequalities in purchase of mosquito nets and willingness to pay for insecticide-treated nets in Nigeria: challenges for malaria control interventions. Malar J 2004 2.23
18 Employment preferences of public sector nurses in Malawi: results from a discrete choice experiment. Trop Med Int Health 2008 2.20
19 Costs and effects of the Tanzanian national voucher scheme for insecticide-treated nets. Malar J 2008 2.07
20 The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malar J 2011 2.03
21 How to do (or not to do) ... Designing a discrete choice experiment for application in a low-income country. Health Policy Plan 2008 2.01
22 Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. Malar J 2009 1.94
23 Delivery systems for insecticide treated and untreated mosquito nets in Africa: categorization and outcomes achieved. Health Policy Plan 2007 1.92
24 What do we mean by rigorous health-systems research? Lancet 2008 1.89
25 Costing the distribution of insecticide-treated nets: a review of cost and cost-effectiveness studies to provide guidance on standardization of costing methodology. Malar J 2006 1.73
26 Are malaria treatment expenditures catastrophic to different socio-economic and geographic groups and how do they cope with payment? A study in southeast Nigeria. Trop Med Int Health 2009 1.72
27 Assessment of a national voucher scheme to deliver insecticide-treated mosquito nets to pregnant women. CMAJ 2010 1.71
28 Which family members use the best nets? An analysis of the condition of mosquito nets and their distribution within households in Tanzania. Malar J 2010 1.67
29 Malaria eradication: the economic, financial and institutional challenge. Malar J 2008 1.62
30 An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines. Health Aff (Millwood) 2009 1.59
31 Horizontal equity in utilisation of care and fairness of health financing: a comparison of micro-health insurance and user fees in Rwanda. Health Econ 2006 1.57
32 Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania. Malar J 2008 1.55
33 NEWHINTS cluster randomised trial to evaluate the impact on neonatal mortality in rural Ghana of routine home visits to provide a package of essential newborn care interventions in the third trimester of pregnancy and the first week of life: trial protocol. Trials 2010 1.50
34 Methods for implementing a medicine outlet survey: lessons from the anti-malarial market. Malar J 2013 1.37
35 Donor funding for newborn survival: an analysis of donor-reported data, 2002-2010. PLoS Med 2012 1.27
36 Some indicators of socio-economic status may not be reliable and use of indices with these data could worsen equity. Health Econ 2006 1.27
37 Do poor people use poor quality providers? Evidence from the treatment of presumptive malaria in Nigeria. Trop Med Int Health 2011 1.26
38 Examining catastrophic health expenditures at variable thresholds using household consumption expenditure diaries. Trop Med Int Health 2011 1.25
39 Methods for studying private sector supply of public health products in developing countries: a conceptual framework and review. Soc Sci Med 2003 1.22
40 From intervention to impact: modelling the potential mortality impact achievable by different long-lasting, insecticide-treated net delivery strategies. Malar J 2012 1.19
41 Examining inequities in incidence of catastrophic health expenditures on different healthcare services and health facilities in Nigeria. PLoS One 2012 1.18
42 A cost function for HIV prevention services: is there a 'u' - shape? Cost Eff Resour Alloc 2007 1.18
43 Low coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: demand-side influences. Malar J 2012 1.16
44 Who buys insecticide-treated nets? Implications for increasing coverage in Nigeria. Health Policy Plan 2003 1.14
45 Methods for evaluating delivery systems for scaling-up malaria control intervention. BMC Health Serv Res 2010 1.13
46 Financial incentives for maternal health: impact of a national programme in Nepal. J Health Econ 2011 1.12
47 The use of discrete choice experiments to inform health workforce policy: a systematic review. BMC Health Serv Res 2014 1.11
48 The economics of social marketing: the case of mosquito nets in Tanzania. Soc Sci Med 2005 1.11
49 Evaluating delivery systems: complex evaluations and plausibility inference. Am J Trop Med Hyg 2010 1.10
50 Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya. Malar J 2012 1.09
51 International flow of Zambian nurses. Hum Resour Health 2009 1.04
52 Integrated surveys of neglected tropical diseases in southern Sudan: how much do they cost and can they be refined? PLoS Negl Trop Dis 2010 1.03
53 Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors. Malar J 2012 1.02
54 Timing of delivery of malaria preventive interventions in pregnancy: results from the Tanzania national voucher programme. J Epidemiol Community Health 2009 1.01
55 Geographic inequities in provision and utilization of malaria treatment services in southeast Nigeria: diagnosis, providers and drugs. Health Policy 2010 1.01
56 Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveys. Trop Med Int Health 2015 1.00
57 Two-tier charging strategies in public hospitals: implications for intra-hospital resource allocation and equity of access to hospital services. J Health Econ 2006 0.99
58 Do divergences between stated and actual willingness to pay signify the existence of bias in contingent valuation surveys? Soc Sci Med 2005 0.96
59 Constraints to universal coverage: inequities in health service use and expenditures for different health conditions and providers. Int J Equity Health 2011 0.96
60 Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention. Malar J 2014 0.96
61 Reading speed does not benefit from increased line spacing in AMD patients. Optom Vis Sci 2008 0.92
62 Appealing to altruism: an alternative strategy to address the health workforce crisis in developing countries? J Public Health (Oxf) 2012 0.91
63 Comparative analysis of two methods for measuring sales volumes during malaria medicine outlet surveys. Malar J 2013 0.91
64 Early career retention of Malawian medical graduates: a retrospective cohort study. Trop Med Int Health 2014 0.90
65 What can be done about the private health sector in low-income countries? World Hosp Health Serv 2002 0.90
66 Are the poor differentially benefiting from provision of priority public health services? A benefit incidence analysis in Nigeria. Int J Equity Health 2012 0.89
67 Purchasing health care in China: experiences, opportunities and challenges. Adv Health Econ Health Serv Res 2009 0.89
68 Financing incidence analysis of household out-of-pocket spending for healthcare: getting more health for money in Nigeria? Int J Health Plann Manage 2013 0.86
69 Price discrimination in obstetric services--a case study in Bangladesh. Health Econ 2004 0.86
70 Markets for hospital services in Zambia. Int J Health Plann Manage 2002 0.86
71 Estimating the demand for health services in four poor districts of Cape Town, South Africa. Int Health 2011 0.86
72 Construct validity of the bidding game, binary with follow-up, and a novel structured haggling question format in determining willingness to pay for insecticide-treated mosquito nets. Med Decis Making 2008 0.83
73 Valuing the benefits of a health intervention using three different approaches to contingent valuation: re-treatment of mosquito bed-nets in Nigeria. J Health Serv Res Policy 2004 0.83
74 Do equity funds protect the poor? Case studies from north-western Madagascar. Health Policy Plan 2012 0.83
75 Inter-rater and test-retest reliability of three contingent valuation question formats in south-east Nigeria. Health Econ 2005 0.81
76 The impact of micro health insurance on Rwandan health centre costs. Health Policy Plan 2006 0.81
77 Price subsidies and the market for mosquito nets in developing countries: A study of Tanzania's discount voucher scheme. Soc Sci Med 2011 0.80
78 Do clinical guidelines reduce clinician dependent costs? Health Res Policy Syst 2011 0.76
79 Health service availability and health seeking behaviour in resource poor settings: evidence from Mozambique. Health Econ Rev 2015 0.75
80 Evaluation of the Affordable Medicines Facility--malaria - Authors' reply. Lancet 2013 0.75
81 Innovations in health system finance in developing and transitional economies. Adv Health Econ Health Serv Res 2009 0.75